Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

NCT03197740 is registered in ClinicalTrials.gov with Icure Pharmaceutical Inc. as lead sponsor.

NCT NCT03197740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03197740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease
Lead sponsor
Icure Pharmaceutical Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 12, 2017
Completion date
July 20, 2020
Enrollment
399 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease